Health Care & Life Sciences » Pharmaceuticals | Peak Pharmaceuticals Inc.

Peak Pharmaceuticals Inc. | Balance Sheet

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
4.90
451.40
201.70
1.30
3.00
Other Current Assets
-
6.80
57.60
-
-
Total Current Assets
4.90
458.30
259.30
1.30
3.00
Net Property, Plant & Equipment
-
-
1.30
-
-
Intangible Assets
-
30.10
18.20
-
-
Other Assets
-
2.50
2.50
-
-
Total Assets
4.90
490.90
281.40
1.30
3.00
ST Debt & Current Portion LT Debt
-
-
-
-
25.00
Accounts Payable
9.60
54.40
-
-
-
Other Current Liabilities
34.50
-
288.60
142.80
170.70
Total Current Liabilities
44.10
54.40
288.60
142.80
195.70
Total Liabilities
44.10
54.40
288.60
142.80
195.70
Common Equity (Total)
39.20
436.50
7.30
141.50
192.70
Total Shareholders' Equity
39.20
436.50
7.30
141.50
192.70
Total Equity
39.20
436.50
7.30
141.50
192.70
Liabilities & Shareholders' Equity
4.90
490.90
281.40
1.30
3.00

About Peak Pharmaceuticals

View Profile
Address
700 North Colorando Boulevard
Denver Colorado 80206
United States
Employees -
Website -
Updated 07/08/2019
Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Denver, CO. .